Outlive
LongevityResearchHub
Preliminary — 28/100 Animal Model bioRxiv

Silencing a protein called CG42795 boosts autophagy and extends lifespan in fruit flies

The GTPase-activating protein CG42795 is a potent neuronal regulator of ageing in Drosophila melanogaster

biorxiv (preprint) Falcsik, G.; Keresztes, F.; Juhasz, A.; Simon-Vecsei, Z.; Kolacsek, O.; Szenci, G.; Takats, S.; Lorincz, P.; Orban, T. I.; Kovacs, T.
TL;DR

Researchers identified a protein (CG42795) that, when silenced in neurons, enhances cellular cleanup (autophagy) and extends lifespan in fruit flies. The same mechanism works in human cells, suggesting a new therapeutic target for age-related diseases.

Credibility Assessment Preliminary — 28/100
Study Design
Rigor of the research methodology
6/20
Sample Size
Whether the study was sufficiently powered
6/20
Peer Review
Review status and journal reputation
3/20
Replication
Has this finding been independently reproduced?
4/20
Transparency
Funding disclosure and data availability
9/20
Overall
Sum of all five dimensions
28/100

What this means

This is early-stage research showing a promising new target (CG42795/TBC1D30) for enhancing cellular autophagy and extending lifespan in model organisms. It's worth following, but it's far too preliminary to guide any clinical decisions—peer review and mammalian validation are essential next steps.

Red Flags: Preprint status (not peer-reviewed). No citation history. Sample sizes for lifespan studies in Drosophila not explicitly stated in abstract. No mention of data availability or preregistration. HeLa cells are immortalized cancer cells, not primary neurons—relevance to aging is indirect. No comparator drugs tested (e.g., rapamycin). Funded by what appears to be institutional sources (not stated), so conflict of interest risk is low but transparency could be higher.

Cells accumulate damaged proteins and dysfunctional organelles over time—a major driver of aging. Autophagy is the cellular 'garbage disposal' that removes this waste, but autophagy declines with age. This creates a vicious cycle: aging neurons can't clean house efficiently, toxic proteins build up, and age-related diseases accelerate. Finding ways to restore autophagy in long-lived, non-dividing cells like neurons is therefore a high-priority goal in aging research.

This team took a systematic approach: they used RNA interference (genetic silencing) to test 12 different GTPase-activating proteins (GAPs) in fruit fly neurons, looking for which ones enhanced the activity of Rab2, a small GTPase that regulates autophagosome–lysosome fusion. CG42795 emerged as a top candidate. When they silenced this gene in fly neurons, they observed more Rab2-positive structures (autophagosomes), improved locomotor ability, and significantly extended lifespan.

Crucially, they validated the mechanism in human cells (HeLa): silencing TBC1D30, the human orthologue of CG42795, similarly boosted Rab2 activity and autophagy. This cross-species conservation is encouraging, suggesting the finding isn't a fruit-fly quirk. However, the paper is preliminary—it's a preprint with no citations yet and hasn't undergone peer review. The exact molecular mechanism of how CG42795 inhibition enhances Rab2 activation remains incompletely characterized.

Key limitations include: (1) results are in invertebrate and cancer cell lines, not mammalian neurons; (2) long-term safety and specificity of CG42795 inhibition in vivo are untested; (3) the preprint format means peer reviewers haven't yet scrutinized methodology, sample sizes, or statistics; (4) no data on whether effects are cell-autonomous or require systemic changes; (5) no comparison to established autophagy enhancers like rapamycin or spermidine.

This work opens an interesting avenue: GAPs are understudied in aging biology, and identifying the right one to inhibit could eventually lead to safer autophagy activators than current options. But the bridge from fruit flies to human therapeutic use is long. The authors correctly position this as a proof-of-concept warranting follow-up, not a near-term drug target.

Autophagy Biomarkers of Aging mTOR Pathway
View Original Source

0 Comments